VisualDx, a diagnostic clinical decision support system, has teamed up with the American Medical Women’s Association (AMWA) to provide access to its technology for free to all members. Through the ...

In what's believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at The University of Texas MD Anderson Cancer Center have found that the commercial ...

Cognoa, maker of the first FDA-approved autism diagnostic tool, announced Highmark has signed on as its first commercial payer partner. The tool, Canvas Dx, will now be reimbursed for commercial ...

EarliTec Diagnostics announced it has received FDA 510(k) clearance for a device that helps clinicians identify autism spectrum disorder for children between the ages of 16 and 30 months old. The tool ...

There was a time when researchers and clinicians debated about whether chronic fatigue syndrome was a disease or if people were imagining their symptoms. Over time, patients were vindicated and it was ...

Two new autism detection methods are promising to offer clinicians objective diagnostic tools that are not based on subjective behavioral assessments. Both systems are in early stages of clinical ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

A New York-based company won a grant from the Bill & Melinda Gates Foundation to build a diagnostic tool that can work without an internet connection. VisualDx won a $655,535 grant, which it will use ...

In their quests to become practicing physicians, medical students perform amazing feats of memorization to gain a rich understanding of the language and process of medicine. Despite their best efforts ...